Published in:
01-12-2019 | Dyslipidemia
Observational Study Investigating the Prescription of Lipid-Lowering Drugs for Primary and/or Secondary Prevention in Residents Aged 80 Years and Over Institutionalized in Nursing Homes in Brest
Published in: The journal of nutrition, health & aging | Issue 10/2019
Login to get accessAbstract
Objectives
To evaluate the prescription of lipid-lowering therapy in nursing home residents aged 80 and older.
Design
Observational descriptive study, led in Brest, France, between February and May 2017.
Setting
15 nursing homes in Brest, France.
Participants
Nursing home residents, aged 80 and older, treated with a lipid-lowering therapy for primary and / or secondary prevention.
Measurements
The primary endpoint was to observe the frequency of prescription of lipid-lowering therapy at the time of the study. The secondary endpoints were to analyse the relevance of these prescriptions regarding the latest French recommendations and current literature data and to evaluate the monitoring of treatment.
Results
213 of the 1121 included residents (19%) were treated with a lipid-lowering drugs. A total of 141 prescriptions (66.2%) were considered irrelevant. In the past 12 months, monitoring of lipids, liver and muscle enzymes was observed respectively in 41.3%, 60.1% and 9.4% of residents.
Conclusion
lipid-lowering prescription was not optimal in nursing homes. The results highlighted inadequate treatment monitoring and a gap between the French National Authority for Health (HAS) recommendations and actual practice.